Corbus Pharmaceuticals Holdings, Inc. (CRBP): Price and Financial Metrics
CRBP Price/Volume Stats
| Current price | $6.74 | 52-week high | $13.17 |
| Prev. close | $6.66 | 52-week low | $2.11 |
| Day low | $6.28 | Volume | 4,000 |
| Day high | $6.74 | Avg. volume | 173,919 |
| 50-day MA | $6.71 | Dividend yield | N/A |
| 200-day MA | $6.55 | Market Cap | 29.82M |
CRBP Stock Price Chart Interactive Chart >
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Company Bio
Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. The company is based in Norwood, Massachusetts.
Latest CRBP News From Around the Web
Below are the latest news stories about CORBUS PHARMACEUTICALS HOLDINGS INC that investors may wish to consider to help them evaluate CRBP as an investment opportunity.
Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateCorbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today provided a corporate update and reported financial results for the second quarter of 2023. |
Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology ConferenceCorbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fireside chat and one-on-one investor meetings at the BTIG Virtual Biotechnology Conference, to be held August 7-8, 2023. |
26 Biggest Marijuana Companies in the WorldThis article will discuss the 26 biggest marijuana companies in the world, understand some recent industry trends, and navigate the future of the marijuana industry. If you want to skip our detailed analysis, you can head directly to the 5 Biggest Marijuana Companies in the World. An Analysis of the Cannabis Industry According to a […] |
Corbus Pharmaceuticals Set to Join Russell Microcap® IndexCorbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that the Company is set to join the Russell Microcap® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens today, as part of the 2023 Russell indexes reconstitution. |
Corbus Pharmaceuticals to Participate in the 2023 Jefferies Healthcare ConferenceCorbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference, to be held in New York, NY June 7-9, 2023. Management will also be available for one-on-one investor meetings during the conference. |
CRBP Price Returns
| 1-mo | -7.67% |
| 3-mo | -14.03% |
| 6-mo | 5.31% |
| 1-year | 36.16% |
| 3-year | -87.52% |
| 5-year | -97.00% |
| YTD | 103.32% |
| 2022 | -82.05% |
| 2021 | -50.74% |
| 2020 | -77.11% |
| 2019 | -6.51% |
| 2018 | -17.75% |
Continue Researching CRBP
Here are a few links from around the web to help you further your research on Corbus Pharmaceuticals Holdings Inc's stock as an investment opportunity:Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Price | Nasdaq
Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Quote, History and News - Yahoo Finance
Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...